Direct purchaser defends US antitrust case over Colcrys
MLex Summary: Value Drug Co. opposed a motion for judgment against claims that Watson Laboratories, Teva Pharmaceutical, Amneal Pharmaceuticals, and Takeda conspired to allocate the generic Colcrys market and delay entry...To view the full article, register now.
Already a subscriber? Click here to view full article